Related Experiment Videos
Platelet-inhibitor drugs' role in coronary artery disease
Progress in Cardiovascular Diseases
|March 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
HDL therapy today: from atherosclerosis, to stent compatibility to heart failure.
Annals of medicine·2019
LDL cholesterol-lowering therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
Drugs of today (Barcelona, Spain : 1998)·2019
Dual versus triple antithrombotic therapy: is there a role for direct oral anticoagulants in arterial thrombosis?
Drugs of today (Barcelona, Spain : 1998)·2019
Muramidase: A useful monocyte/macrophage immunocytochemical marker in swine, of special interest in experimental cardiovascular disease.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation.
Journal of thrombosis and haemostasis : JTH·2012
Cardio-metabolic biomarkers including circulating ketone bodies and risk of incident atrial fibrillation in the multi-ethnic study of atherosclerosis (MESA).
Progress in cardiovascular diseases·2026
Early aortic valve replacement for asymptomatic severe aortic stenosis: an updated systematic review and meta-analysis.
Progress in cardiovascular diseases·2026
Epicardial adipose tissue attenuation as an independent marker of cardiovascular outcomes in de novo heart failure (RECOVER-EAT).
Progress in cardiovascular diseases·2026
Back to the future: Revisiting "leave nothing behind" when managing coronary artery disease.
Progress in cardiovascular diseases·2026
Relationship between pancoronary inflammation and clinical outcome: a 3-vessel OCT study.
Progress in cardiovascular diseases·2026
Genetic testing for dilated and arrhythmogenic cardiomyopathies - A primer for cardiologists.
Progress in cardiovascular diseases·2026